Loading organizations...
Key people at Lallemand.
Lallemand specializes in the development, production, and marketing of microorganisms and their derivatives, offering tailored microbiological solutions across a multitude of industries. The company leverages extensive research and development with a global team of scientists to produce yeasts, bacteria, and other microorganisms that address specific needs in diverse sectors. Their technical approach involves cultivating and applying these living organisms and their byproducts to create functional ingredients and solutions for various applications.
The company was founded in Montreal, Canada, at the close of the 19th century by Fred A. Lallemand, a young entrepreneur of Alsatian ancestry. Lallemand initially focused on supplying raw materials for the baking industry, building a key production plant in 1915 and commencing baker's yeast production by 1923, an early insight into the industrial potential of microorganisms. The business transitioned to the Chagnon family, who acquired it in 1952 and have maintained ownership across three generations.
Lallemand serves a broad B2B customer base, providing solutions for human and animal nutrition, agriculture, winemaking, brewing, and health solutions, among others, with a global presence across five continents. The company’s vision is centered on continuous innovation and strategic expansion, aiming to bring sustained value to its partners and customers worldwide. This forward-looking approach involves ongoing investments in product development and global infrastructure, solidifying its leadership in microorganism-based applications.
Key people at Lallemand.
Lallemand has 1 tracked investment across 1 company. The latest tracked deal is $28.3M Series B in Revyve in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 23, 2025 | Revyve | $28.3M Series B | Hanna Zwietering | Oscar Elderink, Ingrid Nieweg, MSC, Grey Silo Ventures, Royal Cosun |